Table 4.

Treatment of Manifestations in Individuals with Perrault Syndrome

Manifestation/
Concern
TreatmentConsiderations/Other
Hearing loss Possible interventions:
  • Hearing aids
  • Vibrotactile devices
  • Cochlear implantation 1
  • Assessment & treatment by multidisciplinary team incl: audiologist, otolaryngologist, speech therapist
  • Provide for any special educational needs.
  • Early intervention in young children w/profound hearing loss improves cognitive & language development.
Ovarian insufficiency In adolescents presenting w/primary amenorrhea, induction of puberty w/incremental doses of estrogen
  • In consultation w/pediatric endocrinologist
  • If puberty is complete, administer cyclic estrogen & progesterone to mimic menstrual cycle & trigger withdrawal bleeding.
  • Estrogen replacement therapy (if no contraindications) until age ≥50 yrs to ↓ risks of cardiovascular disease & osteoporosis
Assisted reproduction through in vitro fertilization
  • For women w/gonadal dysgenesis: consider assisted reproduction through in vitro fertilization using donor eggs.
  • For women at risk for ovarian insufficiency: consider oocyte cryopreservation if ovarian function is sufficiently well preserved to allow for successful harvesting of oocytes.
  • Consider use of donor eggs.
  • Before considering pregnancy, assess uterine size.
1.

Cochlear implantation can be considered in children age >12 months with severe-to-profound hearing loss.

From: Perrault Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.